BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32290091)

  • 1. Interpretation of the Epigenetic Signature of Facioscapulohumeral Muscular Dystrophy in Light of Genotype-Phenotype Studies.
    Nikolic A; Jones TI; Govi M; Mele F; Maranda L; Sera F; Ricci G; Ruggiero L; Vercelli L; Portaro S; Villa L; Fiorillo C; Maggi L; Santoro L; Antonini G; Filosto M; Moggio M; Angelini C; Pegoraro E; Berardinelli A; Maioli MA; D'Angelo G; Di Muzio A; Siciliano G; Tomelleri G; D'Esposito M; Della Ragione F; Brancaccio A; Piras R; Rodolico C; Mongini T; Magdinier F; Salsi V; Jones PL; Tupler R
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large genotype-phenotype study in carriers of D4Z4 borderline alleles provides guidance for facioscapulohumeral muscular dystrophy diagnosis.
    Ricci G; Mele F; Govi M; Ruggiero L; Sera F; Vercelli L; Bettio C; Santoro L; Mongini T; Villa L; Moggio M; Filosto M; Scarlato M; Previtali SC; Tripodi SM; Pegoraro E; Telese R; Di Muzio A; Rodolico C; Bucci E; Antonini G; D'Angelo MG; Berardinelli A; Maggi L; Piras R; Maioli MA; Siciliano G; Tomelleri G; Angelini C; Tupler R
    Sci Rep; 2020 Dec; 10(1):21648. PubMed ID: 33303865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy.
    Ruggiero L; Mele F; Manganelli F; Bruzzese D; Ricci G; Vercelli L; Govi M; Vallarola A; Tripodi S; Villa L; Di Muzio A; Scarlato M; Bucci E; Antonini G; Maggi L; Rodolico C; Tomelleri G; Filosto M; Previtali S; Angelini C; Berardinelli A; Pegoraro E; Moggio M; Mongini T; Siciliano G; Santoro L; Tupler R
    JAMA Netw Open; 2020 May; 3(5):e204040. PubMed ID: 32356886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-genotype relations in facioscapulohumeral muscular dystrophy type 1.
    Mul K; Voermans NC; Lemmers RJLF; Jonker MA; van der Vliet PJ; Padberg GW; van Engelen BGM; van der Maarel SM; Horlings CGC
    Clin Genet; 2018 Dec; 94(6):521-527. PubMed ID: 30211448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 FSHD with 6-10 Repeated Units: Factors Underlying Severity in Index Cases and Disease Penetrance in Their Relatives Attention.
    Salort-Campana E; Fatehi F; Beloribi-Djefaflia S; Roche S; Nguyen K; Bernard R; Cintas P; Solé G; Bouhour F; Ollagnon E; Sacconi S; Echaniz-Laguna A; Kuntzer T; Levy N; Magdinier F; Attarian S
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large scale genotype-phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy.
    Ricci G; Scionti I; Sera F; Govi M; D'Amico R; Frambolli I; Mele F; Filosto M; Vercelli L; Ruggiero L; Berardinelli A; Angelini C; Antonini G; Bucci E; Cao M; Daolio J; Di Muzio A; Di Leo R; Galluzzi G; Iannaccone E; Maggi L; Maruotti V; Moggio M; Mongini T; Morandi L; Nikolic A; Pastorello E; Ricci E; Rodolico C; Santoro L; Servida M; Siciliano G; Tomelleri G; Tupler R
    Brain; 2013 Nov; 136(Pt 11):3408-17. PubMed ID: 24030947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers.
    Gaillard MC; Roche S; Dion C; Tasmadjian A; Bouget G; Salort-Campana E; Vovan C; Chaix C; Broucqsault N; Morere J; Puppo F; Bartoli M; Levy N; Bernard R; Attarian S; Nguyen K; Magdinier F
    Neurology; 2014 Aug; 83(8):733-42. PubMed ID: 25031281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling.
    Scionti I; Fabbri G; Fiorillo C; Ricci G; Greco F; D'Amico R; Termanini A; Vercelli L; Tomelleri G; Cao M; Santoro L; Percesepe A; Tupler R
    J Med Genet; 2012 Mar; 49(3):171-8. PubMed ID: 22217918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Facioscapulohumeral muscular dystrophy type 2].
    Sacconi S; Desnuelle C
    Rev Neurol (Paris); 2013; 169(8-9):564-72. PubMed ID: 23969240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the 4q35 D4Z4 repeat defines disease status in facioscapulohumeral muscular dystrophy.
    Erdmann H; Scharf F; Gehling S; Benet-Pagès A; Jakubiczka S; Becker K; Seipelt M; Kleefeld F; Knop KC; Prott EC; Hiebeler M; Montagnese F; Gläser D; Vorgerd M; Hagenacker T; Walter MC; Reilich P; Neuhann T; Zenker M; Holinski-Feder E; Schoser B; Abicht A
    Brain; 2023 Apr; 146(4):1388-1402. PubMed ID: 36100962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable hypomethylation of D4Z4 in facioscapulohumeral muscular dystrophy.
    van Overveld PG; Enthoven L; Ricci E; Rossi M; Felicetti L; Jeanpierre M; Winokur ST; Frants RR; Padberg GW; van der Maarel SM
    Ann Neurol; 2005 Oct; 58(4):569-76. PubMed ID: 16178028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears.
    Ricci G; Zatz M; Tupler R
    Curr Mol Med; 2014; 14(8):1052-1068. PubMed ID: 25323867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry.
    Nikolic A; Ricci G; Sera F; Bucci E; Govi M; Mele F; Rossi M; Ruggiero L; Vercelli L; Ravaglia S; Brisca G; Fiorillo C; Villa L; Maggi L; Cao M; D'Amico MC; Siciliano G; Antonini G; Santoro L; Mongini T; Moggio M; Morandi L; Pegoraro E; Angelini C; Di Muzio A; Rodolico C; Tomelleri G; Grazia D'Angelo M; Bruno C; Berardinelli A; Tupler R
    BMJ Open; 2016 Jan; 6(1):e007798. PubMed ID: 26733561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of associated alleles and hypomethylation status in the clinical expression of facioscapulohumeral muscular dystrophy].
    Pikó H; Molnár MJ; Herczegfalvi A; Mayer P; Karcagi V
    Orv Hetil; 2011 Sep; 152(39):1576-85. PubMed ID: 21920844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic features of somatic mosaicism in facioscapulohumeral dystrophy.
    Qiu L; Ye Z; Lin L; Wang L; Lin X; He J; Lin F; Xu G; Cai N; Jin M; Chen H; Lin M; Wang N; Wang Z
    J Med Genet; 2020 Nov; 57(11):777-785. PubMed ID: 32170003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity.
    Sacconi S; Camaño P; de Greef JC; Lemmers RJ; Salviati L; Boileau P; Lopez de Munain Arregui A; van der Maarel SM; Desnuelle C
    J Med Genet; 2012 Jan; 49(1):41-6. PubMed ID: 21984748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
    J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
    de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
    Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype and phenotype analysis of 43 Iranian facioscapulohumeral muscular dystrophy patients; Evidence for anticipation.
    Alavi A; Esmaeili S; Nafissi S; Kahrizi K; Najmabadi H
    Neuromuscul Disord; 2018 Apr; 28(4):303-314. PubMed ID: 29402602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digenic Inheritance of Shortened Repeat Units of the D4Z4 Region and a Loss-of-Function Variant in
    Cascella R; Strafella C; Caputo V; Galota RM; Errichiello V; Scutifero M; Petillo R; Marella GL; Arcangeli M; Colantoni L; Zampatti S; Ricci E; Deidda G; Politano L; Giardina E
    Front Neurol; 2018; 9():1027. PubMed ID: 30546343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.